Document is current
Any future updates will be listed below
-
Authors
Kinfe, Thomas
von Willebrand, Nico
Stadlbauer, Andreas
Buchfelder, Michael
Yearwood, Thomas L.
Muhammad, Sajjad
Chaudhry, Shafqat R.
Gravius, Sascha
Randau, Thomas
Winder, Klemens
Maihöfner, Christian
Gravius, Nadine
Magerl, Walter
-
Funding
Funding for this research was provided by:
St.Jude Medical (Study ID #15815)
Projekt DEAL
- License Information
-
More Information
Article History
Received: 12 June 2020
Accepted: 12 October 2020
First Online: 21 October 2020
Ethical approval and consent to participate
: This study was performed according to the guidelines of the latest revision of the declaration of Helsinki. An independent internal local ethical research board/committee (IRB-No. 258/15) approved the study. The study was registered at the 15.11.2016 on German Register for Clinical Trials (DRKS ID 00011267). ExternalRef removed
: All patients provided written informed consent.
: Thomas M. Kinfe has received training support and works as a consultant for Abbott (formerly St. Jude Medical, Inc.) and works as a consultant for Medtronic Inc. Sajjad Muhammad has received Neuromodulation and Pain Fellowship by Abbott Inc. (formerly St. Jude Medical). Thomas L. Yearwood, MD, PhD works as a consultant for St. Jude Medical, Boston Scientific Neuromodulation, Nevro Corp., and Neuronano; he is also the CMO of Meghan Medical.
